tradingkey.logo

Inspire Veterinary Partners Inc

IVP
0.820USD
+0.009+1.08%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
4.38MValor de mercado
PerdaP/L TTM

Inspire Veterinary Partners Inc

0.820
+0.009+1.08%

Mais detalhes de Inspire Veterinary Partners Inc Empresa

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.

Informações de Inspire Veterinary Partners Inc

Código da empresaIVP
Nome da EmpresaInspire Veterinary Partners Inc
Data de listagemAug 30, 2023
CEOMr. Kimball Carr
Número de funcionários113
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 30
Endereço780 Lynnhaven Pkwy #400
CidadeVIRGINIA BEACH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal23452
Telefone17572883088
Sitehttps://www.inspirevet.com/
Código da empresaIVP
Data de listagemAug 30, 2023
CEOMr. Kimball Carr

Executivos da empresa Inspire Veterinary Partners Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Mr. Kevin M. Mcgrath
Mr. Kevin M. Mcgrath
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: ter, 28 de out
Atualizado em: ter, 28 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Armistice Capital LLC
1.64%
UBS Financial Services, Inc.
0.33%
Geode Capital Management, L.L.C.
0.29%
Tower Research Capital LLC
0.07%
Outro
97.66%
Investidores
Investidores
Proporção
Armistice Capital LLC
1.64%
UBS Financial Services, Inc.
0.33%
Geode Capital Management, L.L.C.
0.29%
Tower Research Capital LLC
0.07%
Outro
97.66%
Tipos de investidores
Investidores
Proporção
Hedge Fund
1.72%
Investment Advisor
0.34%
Investment Advisor/Hedge Fund
0.29%
Outro
97.65%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
30
85.70K
2.35%
-162.35K
2025Q2
36
227.92K
10.75%
+186.48K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Armistice Capital LLC
60.00K
1.66%
-142.90K
-70.43%
Jun 30, 2025
UBS Financial Services, Inc.
12.15K
0.34%
+200.00
+1.67%
Jun 30, 2025
Geode Capital Management, L.L.C.
10.62K
0.29%
+580.00
+5.78%
Jun 30, 2025
Tower Research Capital LLC
2.72K
0.08%
+554.00
+25.58%
Jun 30, 2025
Osaic Holdings, Inc.
84.00
0%
-76.00
-47.50%
Jun 30, 2025
Harbour Investments, Inc
54.00
0%
--
--
Jun 30, 2025
MAI Capital Management, LLC
39.00
0%
--
--
Jun 30, 2025
BofA Global Research (US)
19.00
0%
+8.00
+72.73%
Jun 30, 2025
Wells Fargo Advisors
15.00
0%
+11.00
+275.00%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Data
Tipo
Proporção
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
KeyAI